(Q73758090)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Nagler A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Ohana M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Alper R

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Doviner V

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sherman Y

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Rabbani E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Engelhardt D

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Ilan Y

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

363-369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900772%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704145

6 November 2019

exact match

0 references

cites work

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Graft-versus-host disease: implications from basic immunology for prophylaxis and treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Immune responses to dietary antigens: oral tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Induction of oral tolerance towards hepatitis B envelope antigens in a murine model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Cytokine inhibitors and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Cytokine cascades in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Graft-versus-host disease and the Th1/Th2 paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Cytokine dysregulation in chronic graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Allogeneic hematopoietic stem cell transplantation: complications and results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021

Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704145

7 January 2021